arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Trupanion, Inc.

TRUP Health Care Medical Specialities
$27.80
Today
as of Sep 4, 16:55 ET
Last 30 days +9.02% Jul 28 → Sep 04
$23.79 $25.95 $28.11 $30.28 $32.44 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$28.38
High
$28.57
Low
$27.57
Volume
$280,655
Avg Vol
$433,525
Mkt Cap
$1.4B
P/E (TTM)
69.50
Beta
—
52w High
$46.98
52w Low
$21.16
Div Yield
—
Shares Out
$44M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 21:07 Simply Wall St.
Trupanion (TRUP) Rebounds On Subscriber Narrative, Is The Valuation Gap Real?
Aug 26 · 18:27 StockStory
Why Trupanion (TRUP) Shares Are Sliding Today
Aug 26 · 18:23 MT Newswires
Trupanion Shares Drop After Downgrade From Piper Sandler
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$21
$47
26% of range
Avg surprise (last 2)
+429.2%
Avg reaction (last 1)
-0.4%
0% positive
Latest IV / EM
57%
EM ±8.9% · $28 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.60$-0.40$-0.19$0.02$0.22 Actual $-0.60Actual $-0.33Actual $-0.10Actual $-0.16Actual $-0.14Actual $0.03Actual $-0.03Est $-0.04Actual $0.22Est $-0.03Actual $0.13Actual $0.11Actual $0.16 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$103M$206M$309M$413M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.16 — — — — financials
Tue Mar 31, 2026Mar 2026 $0.11 — — — — financials
Tue Sep 30, 2025Sep 2025 $0.13 — — — — financials
Thu Aug 7, 2025Jun/2025 $0.22 $-0.03 +833.3% — — earnings
Thu May 1, 2025Mar/2025 $-0.03 $-0.04 +25.0% — -0.4% earnings
Mon Sep 30, 2024Sep 2024 $0.03 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.14 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.10 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.33 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.60 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$393M$384M—$367M$354M$342M—$327M
Cost of revenue$328M$323M—$307M$299M$291M—$278M
Gross profit————————
Operating income$6M$5M—$6M$2M$-1M—$2M
Net income————————
EPS (diluted)$0.16$0.11—$0.13$0.22$-0.03—$0.03

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$149M$153M$138M$155M$123M$166M$160M$137M
Inventory————————
Total current assets$719M$705M$691M$668M$629M$628M$597M$600M
Total assets$931M$922M$915M$880M$848M$837M$807M$816M
Long-term debt$97M$99M$102M$114M$113M$128M$128M$128M
Total liabilities$521M$527M$531M$512M$492M$503M$484M$496M
Total equity$410M$395M$384M$369M$355M$334M$323M$320M

Implied volatility — last 90 days

31%96%161%225%290% Jun 07 — IV 49% · EM ±6.8%Jun 08 — IV 79% · EM ±10.4%Jun 09 — IV 50% · EM ±6.3%Jun 10 — IV 59% · EM ±7.0%Jun 11 — IV 107% · EM ±11.8%Jun 12 — IV 157% · EM ±16.1%Jun 15 — IV 205% · EM ±14.9%Jun 16 — IV 125% · EM ±7.4%Jun 17 — IV 279% · EM ±11.7%Jun 19 — IV 45% · EM ±9.9%Jun 22 — IV 49% · EM ±10.3%Jun 23 — IV 52% · EM ±10.6%Jun 24 — IV 62% · EM ±12.5%Jun 25 — IV 47% · EM ±9.3%Jun 26 — IV 45% · EM ±8.7%Jun 29 — IV 59% · EM ±10.4%Jun 30 — IV 47% · EM ±8.1%Jul 01 — IV 48% · EM ±8.0%Jul 02 — IV 61% · EM ±9.9%Jul 03 — IV 64% · EM ±9.9%Jul 06 — IV 48% · EM ±6.6%Jul 07 — IV 41% · EM ±5.5%Jul 08 — IV 54% · EM ±6.8%Jul 09 — IV 64% · EM ±7.5%Jul 10 — IV 131% · EM ±14.5%Jul 13 — IV 74% · EM ±6.2%Jul 14 — IV 230% · EM ±16.7%Jul 15 — IV 103% · EM ±6.1%Jul 16 — IV 291% · EM ±12.1%Jul 20 — IV 72% · EM ±17.0%Jul 21 — IV 66% · EM ±15.4%Jul 22 — IV 72% · EM ±16.4%Jul 23 — IV 73% · EM ±16.4%Jul 24 — IV 76% · EM ±16.9%Jul 27 — IV 76% · EM ±15.9%Jul 28 — IV 78% · EM ±15.9%Jul 29 — IV 92% · EM ±18.5%Jul 30 — IV 74% · EM ±14.5%Jul 31 — IV 98% · EM ±18.7%Aug 03 — IV 83% · EM ±14.8%Aug 04 — IV 90% · EM ±15.4%Aug 05 — IV 92% · EM ±15.4%Aug 06 — IV 31% · EM ±5.1%Aug 07 — IV 69% · EM ±10.7%Aug 10 — IV 64% · EM ±8.9%Aug 11 — IV 58% · EM ±7.7%Aug 12 — IV 53% · EM ±6.6%Aug 13 — IV 74% · EM ±8.7%Aug 14 — IV 64% · EM ±7.0%Aug 17 — IV 57% · EM ±4.8%Aug 18 — IV 59% · EM ±4.3%Aug 19 — IV 147% · EM ±8.7%Aug 20 — IV 117% · EM ±4.9%Aug 24 — IV 42% · EM ±8.7%Aug 25 — IV 40% · EM ±8.2%Aug 26 — IV 35% · EM ±7.0%Aug 27 — IV 44% · EM ±8.7%Aug 28 — IV 48% · EM ±9.1%Aug 31 — IV 62% · EM ±11.1%Sep 01 — IV 51% · EM ±8.7%Sep 02 — IV 72% · EM ±12.0%Sep 03 — IV 59% · EM ±9.6%Sep 04 — IV 57% · EM ±8.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in